Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

Childhood Cancer 2016

5 - 7 Sep 2016
Church House Conference Centre, London, United Kingdom
A novel biomarker for paediatic tumours
Dr Kathleen Birley - UCL Institute of Child Health, London, UK
A novel biomarker for paediatic tumours ( Dr Kathleen Birley - UCL Institute of Child Health, London, UK )
5 Oct 2016
Paediatric ALL with brain metastases
Dr Christina Halsey - University of Glasgow, Glasgow, UK
Paediatric ALL with brain metastases ( Dr Christina Halsey - University of Glasgow, Glasgow, UK )
5 Oct 2016
miRNA screening for germ cell tumours
Dr Matthew Murray - University of Cambridge, Cambridge, UK
miRNA screening for germ cell tumours ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )
5 Oct 2016
ALK mutations in paediatric tumours
Dr Suzanne Turner - Cambridge University, Cambridge, UK
ALK mutations in paediatric tumours ( Dr Suzanne Turner - Cambridge University, Cambridge, UK )
5 Oct 2016
Can we reduce exposure to risk factors associated with childhood leukaemia and o...
Dr Mark Miller - UCSF, San Francisco, USA
Can we reduce exposure to risk factors associated with childhood leukaemia and other cancers? ( Dr Mark Miller - UCSF, San Francisco, USA )
29 Sep 2016
Risk factors for childhood cancer: what are the challenges in research?
Dr Kurt Straif - IARC, Lyon, France
Risk factors for childhood cancer: what are the challenges in research? ( Dr Kurt Straif - IARC, Lyon, France )
26 Sep 2016
Genetic polymorphisms associated with childhood AML
Dr Gisele Brisson - Instituto Nacional de Cancer, Rio de Janeiro, Brazil
Genetic polymorphisms associated with childhood AML ( Dr Gisele Brisson - Instituto Nacional de Cancer, Rio de Janeiro, Brazil )
26 Sep 2016
Making sense of genetic associations with childhood leukaemia risk
Prof Mehmet Dorak - Liverpool Hope University, Liverpool, UK
Making sense of genetic associations with childhood leukaemia risk ( Prof Mehmet Dorak - Liverpool Hope University, Liverpool, UK )
26 Sep 2016
Childhood Cancer 2016: The potential of immunotherapy
Dr John Anderson - University College London, London, UK
Childhood Cancer 2016: The potential of immunotherapy ( Dr John Anderson - University College London, London, UK )
26 Sep 2016
Childhood Cancer 2016: Conference review
Prof Persis Amrolia - Great Ormond Street Hopsital for Children, London, UK
Childhood Cancer 2016: Conference review ( Prof Persis Amrolia - Great Ormond Street Hopsital for Children, London, UK )
26 Sep 2016
Childhood leukaemia and natural background radiation
Dr Gerald Kendall - University of Oxford, Oxford, UK
Childhood leukaemia and natural background radiation ( Dr Gerald Kendall -  University of Oxford, Oxford, UK )
23 Sep 2016
Antibody-based and bispecific T-cell dependent therapies
Dr Nai-Kong Cheung - Memorial Sloan Kettering Cancer Center, New York, USA
Antibody-based and bispecific T-cell dependent therapies ( Dr Nai-Kong Cheung - Memorial Sloan Kettering Cancer Center, New York, USA )
23 Sep 2016
NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls
Dr Daniel Lee - University of Virginia, Charlottesville, USA
NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls ( Dr Daniel Lee - University of Virginia, Charlottesville, USA )
23 Sep 2016
Diet, transplacental carcinogenesis and risk to children: results from the NewGe...
Prof Soterios Kyrtopoulos - National Hellenic Research Foundation, Athens, Greec...
Diet, transplacental carcinogenesis and risk to children: results from the NewGeneris project ( Prof Soterios Kyrtopoulos - National Hellenic Research Foundation, Athens, Greece )
23 Sep 2016
Environmental exposure and childhood leukaemia
Prof Denis Henshaw - University of Bristol, Bristol, UK
Environmental exposure and childhood leukaemia ( Prof Denis Henshaw - University of Bristol, Bristol, UK )
23 Sep 2016
The CAR T cell revolution in cancer therapy
Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA
The CAR T cell revolution in cancer therapy ( Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA )
23 Sep 2016
Development of a novel CD19 CAR with improved functionality
Anne Kramer - PhD student, University College London, London, UK
Development of a novel CD19 CAR with improved functionality ( Anne Kramer - PhD student, University College London, London, UK )
23 Sep 2016
Immune strategies for treating neuroblastoma
Dr Karin Straathof - UCL Institute of Child Health, London, UK
Immune strategies for treating neuroblastoma ( Dr Karin Straathof -  UCL Institute of Child Health, London, UK )
23 Sep 2016
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL
Dr Sara Ghorashian - University College London, London, UK
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL ( Dr Sara Ghorashian - University College London, London, UK )
23 Sep 2016
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL
Jessica Timms - PhD student, Newcastle University, Newcastle, UK
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL ( Jessica Timms - PhD student, Newcastle University, Newcastle, UK )
23 Sep 2016